RxDoctor Payments DataLook up a doctor →

Henry Preston, MD

Family Medicine · Georgetown, KYNPI 1154306207

Payments from drug & device makers

$13,602in general payments, 2019–2025

Across 737 payments — averaging $18.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novo Nordisk$1K
  • GSK$1K
  • AstraZeneca$960
  • Lilly USA, LLC$865
  • Pfizer$625
  • plus $5K from 51 others

What the payments were for

  • Food & beverage$13,50699%
  • Education$961%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)175$3,022
Novo Nordisk92$1,403
GSK75$1,346
AstraZeneca38$960
Lilly USA, LLC53$865
Pfizer42$625
Boehringer Ingelheim30$604
Teva Pharmaceuticals USA, Inc.12$349
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC22$312
Amgen14$270
Phathom Pharmaceuticals, Inc.9$268
Novartis16$244
Sumitomo Pharma America, Inc.13$240
Abbott12$235
Inspire Medical Systems, Inc.2$227
Biohaven Pharmaceuticals, Inc.7$218
Axsome Therapeutics, Inc.4$199
Astellas Pharma US Inc11$198
Grifols USA, LLC6$138
Takeda Pharmaceuticals U.S.A., Inc.7$120
Antares Pharma, Inc.6$119
Johnson & Johnson7$114
Bayer6$109
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)6$106
Sunovion Pharmaceuticals Inc.6$103
Exact Sciences6$99
Biohaven Pharmaceutical Holding Company Ltd.5$94
Merck6$89
Otsuka Pharmaceutical Development & Commercialization, Inc.3$69
Lundbeck LLC3$68
Indivior Inc.1$66
Otsuka America Pharmaceutical, Inc.3$62
Sanofi-aventis U.S. LLC4$58
Medtronic3$56
Tolmar, Inc.3$50
Halozyme Inc2$47
Radius Health, Inc.2$40
Hologic Sales And Service, LLC2$39
Corcept Therapeutics2$33
Eisai Inc.2$32
Dexcom, Inc.1$28
Kowa Pharmaceuticals America, Inc.2$26
Alkermes, Inc.1$25
Esperion Therapeutics, Inc.2$25
Azurity Pharmaceuticals, Inc.1$20
Phadia US Inc.1$20
Baxter Healthcare1$17
Mylan Specialty L.p.1$17
Idorsia Pharmaceuticals US Inc1$16
Redhill Biopharma Inc.1$16
Verona Pharma, Inc.1$16
3b Medical, Inc.1$14
Xeris Pharmaceuticals, Inc.1$14
Lucid Diagnostics Inc.1$14
Ironwood Pharmaceuticals, Inc1$13
Amarin Pharma, Inc.1$12
Endogastric Solutions, Inc1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,602 in reported general payments places this provider in the 95th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$87,058
Medicare patients
301
Services billed
1,232

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide122$166,417
JanuviaSitagliptin Phosphate92$120,690
JardianceEmpagliflozin62$92,078
EliquisApixaban84$71,696
FarxigaDapagliflozin Propanediol28$40,539
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$39,165
XifaxanRifaximin12$37,800
XareltoRivaroxaban30$35,764
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog36$16,367
LinzessLinaclotide16$16,186
MounjaroTirzepatide13$13,633
SymbicortBudesonide/Formoterol Fumarate39$13,612
Metformin Hcl281$13,545
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$10,817
Breo ElliptaFluticasone/Vilanterol24$9,640

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,403$166,417122 claims
MerckJanuvia$89$120,69092 claims
Boehringer IngelheimJardiance, Combivent Respimat$604$101,61678 claims
PfizerEliquis$625$71,69684 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$960$64,96782 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$1,346$56,47983 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$312$37,80012 claims
Johnson & JohnsonXarelto$114$35,76430 claims
AbbVieLinzess$3,022$16,18616 claims
Lilly USA, LLCMounjaro$865$13,63313 claims
Astellas Pharma US IncMyrbetriq$198$5,74813 claims
Sanofi-aventis U.S. LLCLantus$58$2,17023 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Georgetown

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →